Hester Biosciences Ltd Consolidated Net Profit up 6% to Rs. 10.75 crore in H1FY24
Mr. Rajiv Gandhi, CEO & MD, Hester Biosciences Ltd Consolidated Financial Highlights (Rs. Crore) Particulars Q2 H1 FY24 FY23 Change % FY24 FY23 Change % Revenue from operations 70.46 73.15 -4% 158.31 123.85 28% EBITDA 13.21 12.75 4% 27.58 20.18 37% PAT (excl. OCI) 4.04 6.60 -39% 10.75 10.16 6% EPS (In Rs. , not […]
Continue Reading